Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HH2I
|
|||
| Former ID |
DIB015921
|
|||
| Drug Name |
CV-9103
|
|||
| Synonyms |
RNActive cancer vaccine, CureVac; Amplified tumor-derived cRNA library autologous cancer vaccine, CureVac; Globin UTR-stabilized mRNAvaccine (gene vector, cancer), CureVac
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1/2 | [1] | |
| Company |
CureVac GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00906243) RNActive-Derived Therapeutic Vaccine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.